Willow Biosciences Inc's market cap is currently ―. The company's EPS TTM is C$-0.06; its P/E ratio is ―; Willow Biosciences Inc is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Income Statement	-
Total Revenue	$ 1.70M	$ 1.03M	$ 51.00K	$ 89.00K	$ 674.00K
Gross Profit	$ 1.70M	$ 1.03M	$ 51.00K	$ 89.00K	$ 674.00K
EBIT	$ -1.08M	$ -1.45M	$ -2.32M	$ -2.68M	$ -2.23M
EBITDA	$ -767.00K	$ -1.10M	$ -1.97M	$ -2.30M	$ -1.67M
Net Income Common Stockholders	$ -1.25M	$ -1.69M	$ -2.36M	$ -2.42M	$ -2.23M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 859.00K	$ 711.00K	$ 1.64M	$ 3.17M	$ 3.68M
Total Assets	$ 3.17M	$ 3.58M	$ 4.57M	$ 6.67M	$ 8.54M
Total Debt	$ 1.76M	$ 1.88M	$ 2.03M	$ 2.16M	$ 1.66M
Net Debt	$ 900.00K	$ 1.17M	$ 392.00K	$ -1.01M	$ -2.02M
Total Liabilities	$ 2.98M	$ 3.63M	$ 3.03M	$ 3.24M	$ 2.77M
Stockholders Equity	$ 195.00K	$ -55.00K	$ 1.54M	$ 3.44M	$ 5.76M
Cash Flow	-
Free Cash Flow	$ -928.00K	$ -733.00K	$ -1.61M	$ -1.12M	$ -2.38M
Operating Cash Flow	$ -908.00K	$ -733.00K	$ -1.75M	$ -1.07M	$ -2.35M
Investing Cash Flow	$ -109.00K	-	$ 135.00K	$ 4.00K	$ -14.00K
Financing Cash Flow	$ 644.00K	$ 346.00K	$ 71.00K	$ 267.00K	$ -115.00K

Currency in USD

Willow Biosciences Inc Earnings and Revenue History

Income Statement >

Willow Biosciences Inc Debt to Assets

Balance Sheet >

Willow Biosciences Inc Cash Flow

Cash Flow >

Willow Biosciences Inc Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing